Sell an Ambulatory Care Service
Learn more
We are an M&A boutique specialized in ambulatory care, healthcare, and financial services across the DACH region.
For more than 25 years, we have supported owners of ambulatory care providers with succession planning, valuation,
buyer outreach, and the successful completion of transactions that protect teams, care delivery, and continuity.
Our process is discreet, structured, and efficient—from the first value-driver check through closing:
robust price analysis, teaser and information memorandum preparation, targeted outreach and qualification of the right buyers,
due diligence coordination, support in contract negotiations, and handover planning. We run the data room,
communication, and timeline rigorously so day-to-day operations stay stable.
- DACH focus: We advise care providers in Germany, Austria, and Switzerland—ambulatory services, out-of-hospital intensive care, intensive-care shared living groups, and inpatient facilities.
- Ambulatory M&A expertise: Service delivery logic, reimbursement realities, quality evidence, payer stability—we translate operational substance into a defensible purchase-price logic.
- Discretion: Controlled outreach, NDA workflow, staged data releases—without creating unrest within the team.
- Deal certainty: Clean documentation, clear risks, and a handover plan—so buyers, banks, and investors can decide quickly.
- Operational relief: We manage the data room, communication, and milestones so operations continue smoothly.
Sell your ambulatory care service—planned, not stressful.
More buyer interest through clear numbers and positioning.
Succession in phases—structured through closing.
A sale works best with a clear roadmap: define objectives, organize numbers and contracts, present routes and capacities realistically,
prepare team and handover planning—and only then approach buyers discreetly. This keeps daily operations stable while the process moves forward professionally.
Buyers in the DACH region mainly assess stability: occupancy/utilization, team structure, route logic, quality level,
reimbursement reliability, payer mix, and personnel risks. If you document these points cleanly, you negotiate on equal footing
and increase your chance of a strong offer.
The typical process: preparation & valuation, teaser & NDA, discreet outreach, indicative offers,
due diligence, contract negotiation, handover, and closing. A structured process reduces friction,
prevents delays, and protects both the team and the people receiving care.
1. Ambulatory care: what is really transferred?
In a sale, it’s not only equipment or vehicles that change hands. What truly transfers is the organization,
processes, team stability, route structure, and the trust of clients and families.
Buyers pay for substance and reliability—not just revenue.
When the handover is prepared professionally, you’re selling a stable care structure that can be integrated and continued.
2. Reasons & timing: when is the best time to sell?
Common drivers include retirement, lack of internal succession, growth pressure, regulatory burden, or the desire to reduce day-to-day load.
The best timing is typically when operations are stable and the sale is not driven by a crisis.
Early planning creates options: more buyer profiles, better terms, a cleaner handover, and less stress.
3. Valuation & price: what matters in ambulatory care?
Valuation is more than an EBITDA formula. In ambulatory care, team retention, utilization,
route logic, quality evidence, reimbursement stability, contract situation, and the payer environment
materially drive the purchase-price range.
We translate these factors into a defensible range that works for strategic buyers, investors, and banks.
4. Structure & legal: share deal or asset deal?
Whether a share deal or asset deal is preferable depends on liability, transferability, risk allocation, and handover planning.
In Germany, Austria, and Switzerland, labor law, data protection, and contractual/reimbursement logic
play a central role.
We coordinate legal and tax partners and keep the deal compliant—without slowing down operations.
5. Data room & documents: the fastest path to trust
A clean data room often determines whether buyers move quickly and seriously. Key items include
annual financial statements/management reports, contract overviews, anonymized client structure, team and shift structure,
quality documentation, and transparent processes and billing.
With staged access, discretion remains protected: teaser first, then NDA, then deeper data as the deal progresses.
6. Buyer groups: who fits your goals?
Typical buyers include care groups, regional networks, financial investors, and successors from management or the team.
Each group values differently: strategics pay for synergies, investors for scalability, management for stability and handover quality.
We steer outreach so purchase price, team retention, and continuity of care can be achieved together.
7. Process: from preparation to closing
A structured process covers preparation & valuation, teaser/information memo, controlled buyer outreach,
indicative offers, due diligence, contract negotiation, signing/closing, and handover planning.
Clear milestones prevent unnecessary loops and create negotiation certainty.
Explaining each phase clearly reduces friction, improves decision quality, and protects daily operations.
8. Visibility & trust: what convinces in the DACH market
People searching for “sell ambulatory care service” expect guidance: valuation, buyer logic, documents,
timeline, and discretion. Strong content explains this precisely and professionally—without marketing fog.
Combined with structured data, fast performance, and clean internal linking, this builds organic visibility.
9. Common mistakes: why deals fail unnecessarily
Typical pitfalls include preparing too late, relying on a single buyer, incomplete documentation,
sharing sensitive information too early, or unclear internal communication. This leads to price pressure,
delays, or deal breaks.
With clear structure, staged access, and professional buyer management, the probability of closing increases significantly.
10. Next steps: start discreetly, decide cleanly
The best start is a confidential first conversation focused on goals, timing, buyer profile, and an initial indicative valuation.
From that, we build a succession roadmap that protects operations, the team, and deal timing.
If you want to approach a sale seriously, structure is the difference: clear data, a clear story, and clear steps—through to a secure closing.
